XML 30 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,908.9 $ 1,049.9
Inventory 2,506.1 2,527.4
Other current assets 615.3 1,182.0
Total current assets 7,108.5 6,859.3
Property, plant and equipment, net 3,249.3 3,309.7
Operating lease assets 389.4 420.0
Intangible assets, net 8,232.9 8,363.0
Goodwill 6,227.4 6,219.2
Deferred tax asset 915.1 928.6
Investments and other assets 681.5 745.0
Total assets 26,804.1 26,844.8 Close
Current liabilities:    
Current portion of term loan 0.0 150.0
Taxes payable 281.6 257.4
Accounts payable 354.5 403.3
Accrued expense and other 2,472.1 2,623.6
Total current liabilities 3,108.2 3,434.3
Notes payable and term loan 6,292.0 6,788.2
Deferred tax liability 590.6 641.8
Long-term operating lease liabilities 367.5 400.0
Other long-term liabilities 556.7 781.1
Total liabilities 10,915.0 12,045.4 Close
Commitments, contingencies and guarantees
Biogen Inc. shareholders’ equity:    
Preferred stock, par value $0.000 per share 0.0 0.0
Common stock, par value $— per share 0.1 0.1
Additional paid-in capital 407.5 302.5
Accumulated other comprehensive income (loss) (146.0) (153.7)
Retained earnings 18,604.6 17,627.6
Treasury stock, at cost (2,977.1) (2,977.1)
Total equity 15,889.1 14,799.4 Close
Total liabilities and equity 26,804.1 26,844.8
Nonrelated Party    
Current assets:    
Accounts receivable, net of allowance for doubtful accounts of $2.5 and $2.4, respectively 1,627.1 1,664.1
Related Party    
Current assets:    
Accounts receivable, net of allowance for doubtful accounts of $2.5 and $2.4, respectively $ 451.1 $ 435.9